Compound that halts growth of malaria parasite created

April 2, 2012

A drug candidate that has shown promise for neutralizing dangerous bacteria also prevents the parasite that causes malaria from growing, new research by a Yale University team headed by Nobel laureate Sidney Altman shows.

The compound created in the labs of Altman and co-senior author Choukri Ben Mamoun at the Yale School of Medicine penetrates and targets molecular machinery that enables the parasite to grow within the cells, according to findings published the week of April 2 in the Proceedings of the National Academy of Sciences.

Malaria sickens more than 200 million people and kills more than a million people annually. The disease is caused by fives species of parasites of the genus Plasmodium, which is transmitted to humans by mosquitoes.

"While we primarily looked at one species of parasite, it is clear the compound also knocks out drug-resistant strains of malaria as well," Altman said. "This compound can wipe out strains that are currently resistant to drugs such as chloroquine and pyrimethamine."

The work is an outgrowth of the discovery by Yale immunobiology professor Alfred L. M. Bothwell of a basic peptide that the Yale team showed can penetrate cell walls and membranes. Altman and colleagues also added a piece of RNA to this peptide which then attaches to produced by parasites within the blood cells. The presence of this complex activates a molecular response that disables the parasite.

Altman's lab has already shown this compound can kill dangerous strains of bacteria and is currently investigating its efficacy in combating infections in . The current paper illustrates the compound's effectiveness in red blood cell tissue culture. Altman stressed that more tests must be conducted to make sure the compound works in animals and people as well.

"It will be some time before this is commercially available," Altman said.

Explore further: Wolbachia bacteria reduce parasite levels and kill the mosquito that spreads malaria

Related Stories

Modified bone drug kills malaria parasite in mice

February 27, 2012

A chemically altered osteoporosis drug may be useful in fighting malaria, researchers report in a new study. Unlike similar compounds tested against other parasitic protozoa, the drug readily crosses into the red blood cells ...

Recommended for you

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

not rated yet Apr 02, 2012
Thank God for Government funding.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.